Sovereign Financial Group Inc. Sells 1,126 Shares of Select Medical Holdings Co. (NYSE:SEM)

Sovereign Financial Group Inc. trimmed its stake in Select Medical Holdings Co. (NYSE:SEM) by 4.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 25,193 shares of the health services provider’s stock after selling 1,126 shares during the period. Sovereign Financial Group Inc.’s holdings in Select Medical were worth $475,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently bought and sold shares of SEM. Choreo LLC acquired a new stake in Select Medical in the 2nd quarter worth $231,000. American Century Companies Inc. acquired a new stake in Select Medical in the 2nd quarter worth $324,000. DekaBank Deutsche Girozentrale acquired a new stake in Select Medical in the 2nd quarter worth $60,000. Envestnet Asset Management Inc. grew its position in Select Medical by 13.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 298,495 shares of the health services provider’s stock worth $10,465,000 after purchasing an additional 35,564 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in Select Medical by 2.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock worth $157,728,000 after purchasing an additional 95,578 shares during the last quarter. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

SEM has been the topic of several research analyst reports. StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. UBS Group decreased their target price on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Finally, Royal Bank of Canada lifted their target price on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $39.50.

Select Medical Trading Up 1.8 %

Shares of NYSE SEM opened at $19.27 on Thursday. Select Medical Holdings Co. has a 1-year low of $18.02 and a 1-year high of $40.98. The company has a market cap of $2.49 billion, a PE ratio of 9.00, a P/E/G ratio of 0.39 and a beta of 1.45. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The company has a 50-day moving average of $24.34 and a two-hundred day moving average of $31.32.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the previous year, the firm posted $0.46 earnings per share. The company’s revenue was up 5.7% on a year-over-year basis. As a group, equities analysts expect that Select Medical Holdings Co. will post 1.97 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were paid a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.59%. The ex-dividend date was Wednesday, November 13th. Select Medical’s dividend payout ratio (DPR) is 23.36%.

Insider Buying and Selling

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now directly owns 30,356 shares of the company’s stock, valued at $605,602.20. The trade was a 14.12 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 17.50% of the stock is currently owned by insiders.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.